Funding
← Back to your selection

Duquesne Family Office

Activity from announced rounds

Activity in this selectionsymbolic-capital-f3f73206
Rounds participated in
4
Confirmed lead rounds
—
4 roles undisclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$542M
4 disclosed · full round size, not this investor’s share

By stage

Series C+3
Series B1

By primary sector

Biotech4

By country

United States4

Rounds

4 in this selection
Ratio Therapeutics

Developing best-in-class radiopharmaceuticals for cancer treatment

$70MSeries C
Role not disclosed
SonoThera

Develops ultrasound-mediated nonviral genetic medicines

$125MSeries B
Role not disclosed
Cellares

Develops automated cell therapy manufacturing platforms

$257MSeries D
Role not disclosed